The ARES project is a collaborative initiative aiming to establish the National Multidisciplinary Research Centre of Excellence for Drug-Resistant Infections, a dynamic platform integrating multiple functions for addressing one of the top ten global health challenges: the antimicrobial resistance (AMR).

ARES combines the expertise of leading research and educational institutions, consolidating Romania's fragmented efforts to tackle AMR through game-changing, cutting-edge research, career development, and capacity building.

ARES embodies a philosophy of integration and innovation, fostering a unified, OneHealth approach across human, animal, and environmental sectors to enhance understanding and management of AMR. Our strategic objectives include developing and validating innovative diagnosis tools and drugs. 

We also aim to develop novel models to study the complex host-pathogen-microbiome-anti-infective drugs crosstalk. This strategy is designed to influence national and international AMR policies through robust data collection, analysis, and strategic partnerships.

ARES will establish a state-of-the-art distributed infrastructure and interactive platform dedicated to AMR research, introduce new antimicrobial drugs and groundbreaking tools for rapid diagnosis of drug-resistant pathogens and antibiotic susceptibility testing, as well as pioneering therapeutic strategies that could be adopted globally, and align with European and global research networks.